Reappraisal of triosephosphate isomerase deficiency

European Journal of Haematology

Volumn 86, Issue 3, 2011, Pages 265-267

  Orosz, Ferenc ^a   Oláh, Judit ^a   Ovádi, Judit ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

TRIOSEPHOSPHATE ISOMERASE;

ALLELE; ANEMIA; BLOOD TRANSFUSION; CLINICAL FEATURE; CODON; ENZYME ACTIVITY; ENZYME DEFICIENCY; HEMOLYTIC ANEMIA; HETEROZYGOTE; HUMAN; INFECTION SENSITIVITY; LETTER; MISSENSE MUTATION; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; NONSENSE MUTATION; PRIORITY JOURNAL; TRIOSEPHOSPHATE ISOMERASE DEFICIENCY;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANEMIA, HEMOLYTIC, CONGENITAL; CHILD, PRESCHOOL; CODON, NONSENSE; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MUTATION; MUTATION, MISSENSE; PROTEIN CONFORMATION; TRIOSE-PHOSPHATE ISOMERASE;

EID: 79951597441     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01484.x     Document Type: Letter

References (13)

1. Schneider AS. Triosephosphate isomerase deficiency: historical perspectives and molecular aspects. Baillieres Best Pract Res Clin Haematol 2000;13:119-40.
2. Orosz F, Oláh J, Ovádi J. Triosephosphate isomerase deficiency: facts and doubts. IUBMB Life 2006;58:703-15.
3. Climent F, Roset F, Repiso A, Pérez de la Ossa P. Red cell glycolytic enzyme disorders caused by mutations: an update. Cardiovasc Hematol Disord Drug Targets 2009;9:95-106.
4. Hollán S, Fujii H, Hirono A, Hirono K, Karro H, Miwa S, Harsányi V, Gyódi E, Inselt-Kovács M. Hereditary triosephosphate isomerase (TPI) deficiency: two severely affected brothers one with and one without neurological symptoms. Hum Genet 1993;92:486-90.
5. Arya R, Lalloz MR, Bellingham AJ, Layton DM. Evidence for founder effect of the Glu104Asp substitution and identification of new mutations in triosephosphate isomerase deficiency. Hum Mutat 1997;10:290-4.
6. Orosz F, Oláh J, Ovádi J. Triosephosphate isomerase deficiency: new insights into an enigmatic disease. Biochim Biophys Acta 2009;1792:1168-74.
7. Fermo E, Bianchi P, Vercellati C, Rees DC, Marcello AP, Barcellini W, Zanella A. Triose phosphate isomerase deficiency associated with two novel mutations in TPI gene. Eur J Haematol 2010; [Epub ahead of print].
8. Rodríguez-Almazán C, Arreola R, Rodríguez-Larrea D, Aguirre-López B, de Gómez-Puyou MT, Pérez-Montfort R, Costas M, Gómez-Puyou A, Torres-Larios A. Structural basis of human triosephosphate isomerase deficiency: mutation E104D is related to alterations of a conserved water network at the dimer interface. J Biol Chem 2008;283:23254-63.
9. Mainfroid V, Terpstra P, Beauregard M, Frére J-M, Mande S, Hol WGJ, Martial J, Goraj K. Three hTIM mutants that provide new insights on why TIM is a dimer. J Mol Biol 1996;257:441-56.
10. Ralser M, Heeren G, Breitenbach M, Lehrach H, Krobitsch S. Triose phosphate isomerase deficiency is caused by altered dimerization - not catalytic inactivity - of the mutant enzymes. PLoS ONE 2006;1:e30.
11. Oláh J, Orosz F, Keseru GM, Kovári Z, Kovács J, Hollán S, Ovádi J. Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease. Biochem Soc Trans 2002;30:30-8.
12. Orosz F, Oláh J, Alvarez M, et al. Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency. Blood 2001;98:3106-12.
13. Orosz F, Vértessy BG, Hollán S, Horányi M, Ovádi J. Triosephosphate isomerase deficiency: predictions and facts. J Theor Biol 1996;182:437-47.